| 2005-06 | Abnormal APP, cholinergic and cognitive function in Ts65Dn Down`s model mice | 서혜명 |
| 2018-04 | Age-associated bimodal transcriptional drift reduces intergenic disparities in transcription | 서혜명 |
| 2017-03 | Age-associated chromatin relaxation is enhanced in Huntington's disease mice | 서혜명 |
| 2017-03 | Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway. | 서혜명 |
| 2016-05 | beta-Lapachone increases phase II antioxidant enzyme expression via NQO1-AMPK/PI3K-Nrf2/ARE signaling in rat primary astrocytes | 서혜명 |
| 2021-03 | Brain Cells Derived from Alzheimer's Disease Patients have Multiple Specific Innate Abnormalities in Energy Metabolism | 서혜명 |
| 2005-05 | Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection | 서혜명 |
| 2018-06 | Cell-Penetrating Peptide-Patchy Deformable Polymeric Nanovehicles with Enhanced Cellular Uptake and Transdermal Delivery | 서혜명 |
| 2008-07 | Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington`s disease patients | 서혜명 |
| 2017-10 | Correction to: Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression. | 서혜명 |
| 2008-03 | Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein:evidence for a functional link between Down syndrome and Alzheimer’s disease | 서혜명 |
| 2021-06 | Dysfunction of X-linked inhibitor of apoptosis protein (XIAP) triggers neuropathological processes via altered p53 activity in Huntingto's disease | 서혜명 |
| 2015-06 | An early endosome regulator, Rab5b, is an LRRK2 kinase substrate | 서혜명 |
| 2008-06 | Effects of Olanzapine on Gene Expression Changes in MK-801-induced Neurotoxicity Using a High-density DNA Microarray | 서혜명 |
| 2007-02 | Efficient Induction of Oligodendrocytes from Human Embryonic Stem Cells | 서혜명 |
| 2016-04 | G2385R and I2020T Mutations Increase LRRK2 GTPase Activity | 서혜명 |
| 2016-05 | GENE THERAPY BY PROTEASOME ACTIVATOR, PA28 gamma, IMPROVES MOTOR COORDINATION AND PROTEASOME FUNCTION IN HUNTINGTON'S DISEASE YAC128 MICE | 서혜명 |
| 2004-09 | Generalized brain and skin proteasome inhibition in huntington`s disease | 서혜명 |
| 2020-01 | Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models | 서혜명 |
| 2018-09 | Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity | 서혜명 |
| 2015-10 | Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease | 서혜명 |
| 2020-03 | Iroquois homeobox protein 2 identified as a potential biomarker for Parkinson's disease | 서혜명 |
| 2015-09 | Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression | 서혜명 |
| 2017-01 | Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase3 and histone deacetylation. | 서혜명 |
| 2015-09 | LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase | 서혜명 |
| 2021-05 | Matrix Metalloproteinase-8 Inhibitor Ameliorates Inflammatory Responses and Behavioral Deficits in LRRK2G2019S Parkinson's Disease Model Mice | 서혜명 |
| 2021-03 | Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington's disease mouse model | 서혜명 |
| 2016-05 | Neuroanatomical Visualization of the Impaired Striatal Connectivity in Huntington's Disease Mouse Model | 서혜명 |
| 2018-05 | Oxidized DJ-1 Levels in Urine Samples as a Putative Biomarker for Parkinson's Disease. | 서혜명 |
| 2020-05 | Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease | 서혜명 |
